peptide 2
General Information
DRACP ID DRACP02568
Peptide Name peptide 2
Sequence KKXWKKWWK
Sequence Length 9
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane lysis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
A20 | Murine B cell lymphoma | Lymphoma | IC50=51.7 ± 6.5 µM | MTT assay | 4 h | 1 |
AT84 | Murine squamous cell carcinoma | Carcinoma | IC50=36.7 ± 9.5 µM | MTT assay | 4 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity MRC-5: IC50=488 ± 52 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification X=Dip (Diphenylalanine)
Chiral L
Physicochemical Information
Formula C63H90N16O8
Absent amino acids ACDEFGHILMNPQRSTVY
Common amino acids K
Mass 145238
Pl 11.4
Basic residues 5
Acidic residues 0
Hydrophobic residues 3
Net charge 5
Boman Index -2076
Hydrophobicity -246.67
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 16500
Absorbance 280nm 2062.5
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 26982623
Title Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide
Doi 10.1021/acs.jmedchem.5b02025
Year 2016
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_11876